2. Academic Validation
  3. The pathogenesis of aging-induced left atrial appendage thrombus formation and cardioembolic stroke in mice is influenced by inflammation-derived matrix metalloproteinases

The pathogenesis of aging-induced left atrial appendage thrombus formation and cardioembolic stroke in mice is influenced by inflammation-derived matrix metalloproteinases

  • Thromb Res. 2023 Apr 26;226:69-81. doi: 10.1016/j.thromres.2023.04.020.
Ruopeng Tan 1,  Mengyang Yuan 1,  Lin Wang 1,  Jingjie Liu 1,  Guinan Jiang 2,  Jiawei Liao 1,  Yun-Long Xia 3,  Xiaomeng Yin 4,  Yang Liu 5
Affiliations

Affiliations

  • 1 Institute of Cardiovascular Diseases, the First Affiliated Hospital of Dalian Medical University, Dalian, China.
  • 2 Department of Interventional Therapy, the First Affiliated Hospital of Dalian Medical University, Dalian, 116011, China.
  • 3 Institute of Cardiovascular Diseases, the First Affiliated Hospital of Dalian Medical University, Dalian, China; Department of Cardiology, the First Affiliated Hospital of Dalian Medical University, Dalian, China.
  • 4 Institute of Cardiovascular Diseases, the First Affiliated Hospital of Dalian Medical University, Dalian, China; Department of Cardiology, the First Affiliated Hospital of Dalian Medical University, Dalian, China. Electronic address: [email protected].
  • 5 Institute of Cardiovascular Diseases, the First Affiliated Hospital of Dalian Medical University, Dalian, China. Electronic address: [email protected].
PMID: 37121014 DOI: 10.1016/j.thromres.2023.04.020
Abstract

Elderly people without atrial fibrillation (AF) still have a high incidence of cardioembolic stroke, suggesting that thrombus formation within the left atrial appendage (LAA) may also occur in an AF-independent manner. In the present study, we explored the potential mechanisms for aging-induced LAA thrombus formation and stroke in mice. We monitored stroke events in 180 aging male mice (14-24 months) and assessed left atrium (LA) remodeling by echocardiography at different ages. Mice that had stroke were implanted with telemeters to confirm AF. Histological features of LA and LAA thrombi were examined, as well as collagen content, expression of Matrix Metalloproteinases (MMPs), and leukocyte density in the atria at different ages, in mice with or without stroke. Also, the effects of MMP inhibition on stroke incidence and atrial inflammation were tested. We detected 20 mice (11 %) with stroke, 60 % of which were within 18-19 months of age. Although we did not detect AF in mice with stroke, we detected the presence of LAA thrombi, suggesting that stroke originated from the hearts of these mice. Compared with 18-month-old mice without stroke, 18-month-old stroke mice had enlarged LA with a very thin endocardium, that was associated with less collagen and heightened MMP expression in the atria. During aging, we found that the expression of mRNAs for atrial MMP7, MMP8, and MMP9 peaked at 18 months, which closely correlated with reductions in collagen content and the time-window for cardioembolic stroke in these mice. Treatment of mice with an MMP Inhibitor at 17-18 months of age reduced atrial inflammation and remodeling, and stroke incidence. Taken together, our study demonstrates that aging-induced LAA thrombus formation occurs through a mechanism involving upregulation of MMPs and breakdown of collagen, and that treatment with an MMP Inhibitor may be effective as a treatment strategy for this heart condition.

Keywords

Aging; Atrial myopathy; Inflammation; Stroke; Thrombus.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-19485
    98.13%, MMP Inhibitor